THIS NEW PROSPECT FOR WEIGHT REGULATION?

Scientists are excitedly investigating retatrutide, a promising drug developed by Eli Lilly, as a possible step in body management. Unlike many previous approaches, retatrutide is a twin-action agonist targeting equally GLP-1 and GIP, hormones that influence appetite and blood sugar balance. Ini